Study of Regorafenib and Sildenafil for Advanced Solid Tumors

NCT02466802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Regorafenib
DRUG: Sildenafil Citrate

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]